[A rare cause of pulmonary arterial hypertension: Thoracic amyloidosis].

Une cause rare d’hypertension artérielle pulmonaire : l’amylose thoracique.
AL amyloidosis Amylose AL Amylose thoracique Artère pulmonaire Diagnostic imaging Hypertension artérielle pulmonaire Imagerie diagnostique Pulmonary arterial hypertension Pulmonary artery Thoracic amyloidosis

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 30 04 2021
accepted: 06 05 2021
pubmed: 17 6 2021
medline: 4 2 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

Isolated thoracic involvement in amyloidosis is a rare and serious condition. Its association with pulmonary arterial hypertension (PAH) usually weakens the prognosis. We report the case of a 40-year-old man with a smoking history, hospitalized for chest pain, abdominal pain and acute respiratory distress. The cardiac ultrasound revealed a circumferential pericardial effusion as well as a pulmonary artery systolic pressure (PAPS) at 80mmHg. Chest imaging (computed tomography scan and magnetic resonance imaging) showed a tissue process developed in the pericardial sheath (60×45mm) sheathing the ascending aorta and infiltrating the trunk of the pulmonary artery and its right branch. Anatomopathological and immunohistochemical study of the process revealed AL amyloidosis. Note that the patient had no signs of extrathoracic amyloidosis. Blood and urine electrophoresis and immunoelectrophoresis as well as bone marrow mylogram and biopsy were normal. The patient was put on oral anticoagulant as he presented with PAH. A therapeutic protocol with thalidomide and dexamethasone has been initiated. The course of the disease was marked by total regression of the clinical signs, a marked decrease in the amyloid process on imaging and a normalization of the PAPS; our follow-up being three years.

Identifiants

pubmed: 34130803
pii: S0003-3928(21)00066-4
doi: 10.1016/j.ancard.2021.05.002
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

59-62

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

S Toujani (S)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie. Electronic address: sanatoujani1@gmail.com.

A El Ouni (A)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

A Belhassan (A)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

N Ghriss (N)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

Z Meddeb (Z)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

C Abdelkefi (C)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

S Hamzaoui (S)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

T Larbi (T)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

K Bouslama (K)

Service de médecine interne, centre hospitalier universitaire Mongi Slim, La Marsa, Tunisie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH